Cancer Res Treat.  2018 Apr;50(2):317-323. 10.4143/crt.2018.142.

Prediction of Cancer Incidence and Mortality in Korea, 2018

Affiliations
  • 1The Korea Central Cancer Registry, National Cancer Center, Goyang, Korea. astra67@ncc.re.kr
  • 2National Cancer Control Institute, National Cancer Center, Goyang, Korea.
  • 3Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.
  • 4National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.

Abstract

PURPOSE
This study aimed to report on cancer incidence and mortality for the year 2018 to estimate Korea's current cancer burden.
MATERIALS AND METHODS
Cancer incidence data from 1999 to 2015 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2016 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against observed years, then multiplying the projected age-specific rates by the age-specific population. The Joinpoint regression model was used to determine at which year the linear trend changed significantly, we only used the data of the latest trend.
RESULTS
A total of 204,909 new cancer cases and 82,155 cancer deaths are expected to occur in Korea in 2018. The most common cancer sites were lung, followed by stomach, colorectal, breast and liver. These five cancers represent half of the overall burden of cancer in Korea. For mortality, the most common sites were lung cancer, followed by liver, colorectal, stomach and pancreas.
CONCLUSION
The incidence rate of all cancer in Korea are estimated to decrease gradually, mainly due to decrease of thyroid cancer. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluation of cancer-control programs.

Keyword

Incidence; Mortality; Neoplasms; Forecasting; Korea; 2018

MeSH Terms

Breast
Forecasting
Incidence*
Korea*
Linear Models
Liver
Lung
Lung Neoplasms
Mortality*
Pancreas
Stomach
Thyroid Neoplasms

Figure

  • Fig. 1. The 10 leading types of estimated new cancer cases and deaths by sex in 2018. (A) Estimated new cases. (B) Estimated deaths.

  • Fig. 2. Projected age-specific incidences of major cancers during 2018 in Korea. (A) Males. (B) Females.

  • Fig. 3. Projected age-specific mortality rates of major cancers during 2018 in Korea. (A) Males. (B). Females.


Cited by  11 articles

Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy
Hyejeong Hue, Kidong Kim, HyoJin Kim, Dong Hoon Suh, Jae Hong No, Yong Beom Kim
Obstet Gynecol Sci. 2019;62(4):285-289.    doi: 10.5468/ogs.2019.62.4.285.

Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015
Myong Cheol Lim, Young-Joo Won, Mun Jung Ko, Miseon Kim, Seung-Hyuk Shim, Dong Hoon Suh, Jae-Weon Kim
J Gynecol Oncol. 2019;30(1):.    doi: 10.3802/jgo.2019.30.e38.

임상검체에서 BRCA 돌연변이를 검출하는 차세대염기서열분석법의 임상적 효용성 평가
Man Jin Kim, Byeong Ju Song, Si Eun Kim, Chang Seon Lee, Ji-Eun Im, Ensel Oh, Keunsook Lee, Sung Im Cho, Kwang Joong Kim, Sung Sup Park, Moon-Woo Seong
Lab Med Online. 2021;11(4):283-289.    doi: 10.47429/lmo.2021.11.4.283.

Clinical Implementation of Precision Medicine in Gastric Cancer
Jaewook Jeon, Jae-Ho Cheong
J Gastric Cancer. 2019;19(3):235-253.    doi: 10.5230/jgc.2019.19.e25.

Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database
Hyun-Woong Cho, Yung-Taek Ouh, Jae Kwan Lee, Jin Hwa Hong
J Gynecol Oncol. 2019;30(4):e51.    doi: 10.3802/jgo.2019.30.e51.

Demographic and Socioeconomic Factors for Renouncing Further Active Therapy for Patients with Brain Metastasis of Non-Small Cell Lung Cancer
Gyuseo Jung, Seok-Hyun Kim, Tae Gyu Kim, Young Zoon Kim
Brain Tumor Res Treat. 2019;7(2):112-121.    doi: 10.14791/btrt.2019.7.e35.

Lymph node size and its association with nodal metastasis in ductal adenocarcinoma of the pancreas
Jaehoon Shin, Seungbeom Shin, Jae Hoon Lee, Ki Byung Song, Dae Wook Hwang, Hyoung Jung Kim, Jae Ho Byun, HyungJun Cho, Song Cheol Kim, Seung-Mo Hong
J Pathol Transl Med. 2020;54(5):387-395.    doi: 10.4132/jptm.2020.06.23.

Prevalence of Women with Dense Breasts in Korea: Results from a Nationwide Cross-sectional Study
Hye-Mi Jo, Eun Hye Lee, Kyungran Ko, Bong Joo Kang, Joo Hee Cha, Ann Yi, Hae Kyoung Jung, Jae Kwan Jun
Cancer Res Treat. 2019;51(4):1295-1301.    doi: 10.4143/crt.2018.297.

Perspectives on Professional Burnout and Occupational Stress among Medical Oncologists: A Cross-sectional Survey by Korean Society for Medical Oncology (KSMO)
Yun-Gyoo Lee, Chi Hoon Maeng, Do Yeun Kim, Bong-Seog Kim
Cancer Res Treat. 2020;52(4):1002-1009.    doi: 10.4143/crt.2020.190.

Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19
Tung Hoang, Trung Quang Nguyen, Tho Thi Anh Tran
Cancer Res Treat. 2021;53(3):650-656.    doi: 10.4143/crt.2020.950.

Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database
Hyun-Woong Cho, Yung-Taek Ouh, Jin Hwa Hong, Jae Kwan Lee
J Gynecol Oncol. 2019;30(4):.    doi: 10.3802/jgo.2019.30.e51.


Reference

References

1. Statistics Korea [Internet]. Daejeon: Statistics Korea;2018. [cited 2018 Feb 8]. Available from: http://kosis.kr.
2. Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 2017; 49:292–305.
Article
3. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005; 37:325–31.
Article
4. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. 1st rev. ed. Geneva: World Health Organization;2013.
5. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. Geneva: World Health Organization;1994.
6. Boyle P, Parkin DM. Statistical methods for registries. In : Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon: International Agency for Research on Cancer;1991. p. 126–58.
7. National Cancer Institute. Joinpoint regression program, version 4.3.1 [Internet]. Bethesda, MD: National Cancer Institute;2016. [cited 2018 Jan 8]. Available from: http://surveillance.cancer.gov/joinpoint/.
8. Segi M. Cancer mortality for selected sites in 24 countries (1950–1957). Sendai: Tohoku University School of Medicine;1960.
Full Text Links
  • CRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr